visitante ::
identificación
|
|||||||||||||||
Buscar | Enviar | Ayuda | Servicio de Bibliotecas | Sobre el DDD | Català English Español |
Página principal > Artículos > Artículos publicados > Towards Protein-Based Viral Mimetics for Cancer Therapies |
Fecha: | 2015 |
Resumen: | High resistance and recurrence rates, along with elevated drug clearance, compel the use of maximum tolerated drug doses in cancer therapy, resulting in high-grade toxicities and limited clinical applicability. Promoting active drug accumulation in tumor tissues would minimize such issues and improve therapeutic outcomes. A new class of therapeutic drugs suitable for the task has emerged based on the concept of virus-mimetic nanocarriers, or 'artificial viruses. ' Among the spectrum of materials under exploration in nanocarrier research, proteins offer unparalleled structural and functional versatility for designing viruslike molecular vehicles. By exhibiting 'smart' functions and biomimetic traits, protein-based nanocarriers will be a step ahead of the conventional drug-protein conjugates already in the clinics in ensuring efficient delivery of passenger antitumor drugs. |
Ayudas: | Instituto de Salud Carlos III PI12/00327 Instituto de Salud Carlos III PI12/01861 Fundació la Marató de TV3 2013-133930 Fundació la Marató de TV3 2013-132031 Fundació la Marató de TV3 416/C/2013 Ministerio de Economía y Competitividad BIO2013-41019-P |
Derechos: | Tots els drets reservats. |
Lengua: | Anglès |
Documento: | Article de revisió ; Article ; Versió acceptada per publicar |
Materia: | Protein nanoparticles ; Drug delivery ; Biomaterials ; Biomimetics ; Protein engineering ; Targeted therapy |
Publicado en: | Trends in biotechnology, Vol. 33, Issue 5 (Maig 2015) , p. 253-258, ISSN 0167-7799 |
Postprint 19 p, 142.0 KB |
Figure 1 3508x2479, 2.6 MB |
Figure 2 960x720, 79.9 KB |